SUVRETTA CAPITAL MANAGEMENT, LLC - Q2 2021 holdings

Add to watchlist

$6.69 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 122 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 60.4% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
ADBE BuyADOBE SYSTEMS INCORPORATED$371,772,000
+23.6%
634,813
+0.3%
5.56%
+25.0%
AMZN BuyAMAZON COM INC$358,145,000
+49.5%
104,107
+34.5%
5.36%
+51.2%
UNH BuyUNITEDHEALTH GROUP INC$277,030,000
+34.5%
691,813
+25.0%
4.14%
+36.1%
GOOG NewALPHABET INCcap stk cl c$268,600,000–107,169
+100.0%
4.02%–
TPR SellTAPESTRY INC$225,220,000
+1.3%
5,179,862
-4.0%
3.37%
+2.4%
OTIS SellOTIS WORLDWIDE CORP$214,703,000
+9.2%
2,625,693
-8.6%
3.21%
+10.4%
UNP BuyUNION PAC CORP$210,380,000
+4.6%
956,577
+4.8%
3.15%
+5.7%
RH SellRH$206,519,000
+10.9%
304,151
-2.5%
3.09%
+12.2%
MA BuyMASTERCARD INCORPORATEDcl a$198,945,000
+17.7%
544,921
+14.8%
2.98%
+19.0%
UBER SellUBER TECHNOLOGIES INC$193,438,000
-15.7%
3,859,494
-8.3%
2.89%
-14.8%
EL SellLAUDER ESTEE COS INCcl a$163,370,000
-31.8%
513,614
-37.6%
2.44%
-31.0%
MDT SellMEDTRONIC PLC$161,172,000
+0.3%
1,298,416
-4.6%
2.41%
+1.4%
FB NewFACEBOOK INCcl a$161,087,000–463,280
+100.0%
2.41%–
PSFE SellPAYSAFE LIMITEDord$156,429,000
-10.9%
12,917,328
-0.6%
2.34%
-9.8%
GFL BuyGFL ENVIRONMENTAL INC$153,637,000
-3.4%
4,813,175
+5.8%
2.30%
-2.3%
CVNA BuyCARVANA COcl a$144,766,000
+15.5%
479,643
+0.4%
2.16%
+16.8%
IQV SellIQVIA HLDGS INC$144,141,000
-11.5%
594,837
-29.5%
2.16%
-10.5%
ROST BuyROSS STORES INC$138,785,000
+3.6%
1,119,235
+0.2%
2.08%
+4.8%
ABC BuyAMERISOURCEBERGEN CORP$134,481,000
+30.4%
1,174,605
+34.5%
2.01%
+31.9%
TWLO NewTWILIO INCcl a$123,766,000–314,000
+100.0%
1.85%–
OPEN BuyOPENDOOR TECHNOLOGIES INC$118,873,000
+0.8%
6,704,630
+20.5%
1.78%
+1.9%
KBR SellKBR INC$118,714,000
-12.3%
3,111,777
-11.7%
1.78%
-11.2%
PWR BuyQUANTA SVCS INC$115,190,000
+15.7%
1,271,834
+12.4%
1.72%
+17.1%
CPRT NewCOPART INC$109,189,000–828,255
+100.0%
1.63%–
PLAN SellANAPLAN INC$106,896,000
-27.3%
2,005,548
-26.6%
1.60%
-26.5%
AAPL NewAPPLE INC$99,638,000–727,500
+100.0%
1.49%–
PTON NewPELOTON INTERACTIVE INC$90,964,000–733,463
+100.0%
1.36%–
CANO NewCANO HEALTH INC$86,659,000–7,161,896
+100.0%
1.30%–
FIS  FIDELITY NATL INFORMATION SV$85,002,000
+0.8%
600,0000.0%1.27%
+1.8%
NXPI SellNXP SEMICONDUCTORS N V$83,199,000
-40.9%
404,428
-42.2%
1.24%
-40.3%
TEL SellTE CONNECTIVITY LTD$81,738,000
-8.4%
604,527
-12.5%
1.22%
-7.4%
VMEO NewVIMEO INC$80,359,000–1,639,972
+100.0%
1.20%–
WPF BuyFOLEY TRASIMENE ACQUISTN COR$78,636,000
+116.4%
8,048,673
+122.3%
1.18%
+119.0%
EXAS SellEXACT SCIENCES CORP$60,589,000
-48.2%
487,400
-45.0%
0.91%
-47.6%
NVTA BuyINVITAE CORP$58,014,000
+7.5%
1,719,944
+21.8%
0.87%
+8.8%
HWM NewHOWMET AEROSPACE INC$57,248,000–1,660,800
+100.0%
0.86%–
AGIO SellAGIOS PHARMACEUTICALS INC$54,419,000
-2.5%
987,456
-8.7%
0.81%
-1.5%
ADI NewANALOG DEVICES INC$53,652,000–311,640
+100.0%
0.80%–
SOFI NewSOFI TECHNOLOGIES INC$47,925,000–2,500,000
+100.0%
0.72%–
GHVI SellGORES HOLDINGS VI INC$42,986,000
+13.9%
2,651,800
-3.7%
0.64%
+15.2%
ITCI  INTRA-CELLULAR THERAPIES INC$42,403,000
+20.3%
1,038,7700.0%0.63%
+21.7%
NTRA NewNATERA INC$40,156,000–353,700
+100.0%
0.60%–
BLUE SellBLUEBIRD BIO INC$40,057,000
+1.9%
1,252,575
-4.0%
0.60%
+2.9%
GPN  GLOBAL PMTS INC$38,774,000
-7.0%
206,7530.0%0.58%
-5.8%
KURA BuyKURA ONCOLOGY INC$34,584,000
+67.0%
1,658,706
+126.5%
0.52%
+69.0%
 MARINUS PHARMACEUTICALS INC$32,766,000
+15.9%
1,826,4450.0%0.49%
+17.2%
KPLT NewKATAPULT HOLDINGS INC$32,474,000–3,004,034
+100.0%
0.49%–
STRO BuySUTRO BIOPHARMA INC$31,889,000
+9.0%
1,715,381
+33.5%
0.48%
+10.2%
AJAX BuyAJAX I$29,902,000
+34.6%
3,002,193
+38.7%
0.45%
+35.9%
RPRX SellROYALTY PHARMA PLC$29,897,000
-28.4%
729,377
-23.8%
0.45%
-27.6%
S NewSENTINELONE INCcl a$29,793,000–701,000
+100.0%
0.45%–
KALV BuyKALVISTA PHARMACEUTICALS INC$28,539,000
+15.7%
1,191,101
+24.1%
0.43%
+17.0%
SOFI NewSOFI TECHNOLOGIES INCput$27,605,000–1,440,000
+100.0%
0.41%–
MREO BuyMEREO BIOPHARMA GROUP PLCads$27,418,000
+27.8%
8,649,300
+35.9%
0.41%
+29.3%
RAAC BuyREVOLUTION ACCELERTN ACQU CO$24,932,000
-1.6%
2,500,708
+0.0%
0.37%
-0.5%
MRTX NewMIRATI THERAPEUTICS INC$24,047,000–148,872
+100.0%
0.36%–
DCPH BuyDECIPHERA PHARMACEUTICALS IN$23,893,000
+58.2%
652,635
+93.8%
0.36%
+60.1%
HRTX BuyHERON THERAPEUTICS INC$23,132,000
+182.0%
1,490,440
+194.5%
0.35%
+186.0%
AMAM NewAMBRX BIOPHARMA INCsponsored ads$22,923,000–1,169,529
+100.0%
0.34%–
SLDB  SOLID BIOSCIENCES INC$21,866,000
-33.8%
5,974,1930.0%0.33%
-33.1%
RACA BuyTHERAPEUTICS ACQUISITION COR$21,017,000
+85.8%
2,045,600
+90.1%
0.31%
+88.0%
AGC NewALTIMETER GROWTH CORPcl a$20,513,000–1,753,264
+100.0%
0.31%–
FTCV NewFINTECH ACQUISITION CORP V$20,258,000–1,661,845
+100.0%
0.30%–
FBRX SellFORTE BIOSCIENCES INC$17,380,000
-15.5%
516,956
-13.8%
0.26%
-14.5%
FULC BuyFULCRUM THERAPEUTICS INC$17,056,000
-5.1%
1,627,444
+6.7%
0.26%
-4.1%
RXDX BuyPROMETHEUS BIOSCIENCES INC$15,365,000
+45.4%
625,625
+8.1%
0.23%
+47.4%
SIOX  SIO GENE THERAPIES INC$14,985,000
+4.6%
5,489,0000.0%0.22%
+5.7%
BOLT BuyBOLT BIOTHERAPEUTICS INC$14,750,000
+6.6%
954,089
+127.0%
0.22%
+7.8%
AGLE BuyAEGLEA BIOTHERAPEUTICS INC$14,575,000
+34.6%
2,094,100
+53.2%
0.22%
+36.2%
MQ NewMARQETA INC$14,144,000–503,898
+100.0%
0.21%–
GMTX BuyGEMINI THERAPEUTICS INC$13,813,000
-22.3%
2,135,000
+62.7%
0.21%
-21.3%
TERN  TERNS PHARMACEUTICALS INC$13,794,000
-44.3%
1,125,1360.0%0.21%
-43.7%
KDNY BuyCHINOOK THERAPEUTICS INC$13,668,000
+60.0%
968,023
+76.1%
0.20%
+61.9%
OWL NewBLUE OWL CAPITAL INC$12,880,000–1,000,000
+100.0%
0.19%–
INSM NewINSMED INC$12,553,000–441,065
+100.0%
0.19%–
EYPT BuyEYEPOINT PHARMACEUTICALS INC$12,391,000
+3.2%
1,378,332
+16.7%
0.18%
+4.5%
HOL NewHOLICITY INC$12,350,000–1,000,000
+100.0%
0.18%–
XENE BuyXENON PHARMACEUTICALS INC$11,062,000
+40.4%
594,111
+35.0%
0.16%
+42.2%
FSRX NewFINSERV ACQUISITION CORP II$10,631,000–1,092,600
+100.0%
0.16%–
ALUS  ALUSSA ENERGY ACQUISITION CO$9,910,000
-0.9%
1,000,0000.0%0.15%0.0%
IFRX  INFLARX NV$9,756,000
-23.9%
3,285,0000.0%0.15%
-22.8%
TPTX NewTURNING POINT THERAPEUTICS I$9,596,000–122,994
+100.0%
0.14%–
MOLN NewMOLECULAR PARTNERS AGads$8,196,000–400,000
+100.0%
0.12%–
KZR  KEZAR LIFE SCIENCES INC$7,656,000
-8.9%
1,409,9560.0%0.12%
-7.3%
NHIC BuyNEWHOLD INVESTMENT CORP$7,530,000
+0.3%
750,706
+0.1%
0.11%
+1.8%
CMRX SellCHIMERIX INC$6,602,000
-25.2%
825,241
-9.8%
0.10%
-23.8%
INZY BuyINOZYME PHARMA INC$6,223,000
-7.9%
365,172
+7.0%
0.09%
-7.0%
VERV NewVERVE THERAPEUTICS INC$6,025,000–100,000
+100.0%
0.09%–
NEXI SellNEXIMMUNE INC$5,969,000
-46.0%
365,762
-36.9%
0.09%
-45.4%
FIVE SellFIVE BELOW INC$5,921,000
-96.1%
30,636
-96.2%
0.09%
-96.1%
OTIC BuyOTONOMY INC$5,325,000
+1.4%
2,387,700
+15.9%
0.08%
+2.6%
RACB  RESEARCH ALLIANCE CORP II$5,070,000
-1.1%
500,0000.0%0.08%0.0%
MIST  MILESTONE PHARMACEUTICALS IN$4,682,000
-5.0%
851,2910.0%0.07%
-4.1%
FSII  FS DEVELOPMENT CORP II$3,992,000
+0.2%
400,0000.0%0.06%
+1.7%
GRPH NewGRAPHITE BIO INC$3,841,000–125,000
+100.0%
0.06%–
CYT NewCYTEIR THERAPEUTICS INC$3,745,000–175,000
+100.0%
0.06%–
TBLA NewTABOOLA.COM LTD$3,623,000–350,000
+100.0%
0.05%–
GLUE NewMONTE ROSA THERAPEUTICS INC$3,405,000–150,000
+100.0%
0.05%–
BNTC NewBENITEC BIOPHARMA INC$3,268,000–769,000
+100.0%
0.05%–
NAUT NewNAUTILUS BIOTECHNOLOGY INC$3,180,000–314,835
+100.0%
0.05%–
MCW NewMISTER CAR WASH INC$3,230,000–150,000
+100.0%
0.05%–
CLII NewCLIMATE CHANGE CRISIS REAL I$3,004,000–200,000
+100.0%
0.04%–
OMEG  OMEGA ALPHA SPACcl a$2,985,000
+0.5%
300,0000.0%0.04%
+2.3%
EBAC NewEUROPEAN BIOTECH ACQUTN CORP$2,922,000–300,000
+100.0%
0.04%–
HCAQ  HEALTHCOR CATALIO ACQU CORP$2,955,000
-1.5%
300,0000.0%0.04%0.0%
ADAG  ADAGENE INCads$2,766,000
-24.5%
204,0000.0%0.04%
-24.1%
CANOWS NewCANO HEALTH INC*w exp 06/03/202$2,488,000–674,566
+100.0%
0.04%–
DBTX  DECIBEL THERAPEUTICS INC$2,267,000
-24.3%
263,6000.0%0.03%
-22.7%
BLSA  BCLS ACQUISITION CORP$2,106,000
-0.4%
200,0000.0%0.03%0.0%
TMPM  TURMERIC ACQUISITION CORPcl a$1,978,000
+1.2%
200,0000.0%0.03%
+3.4%
SANA SellSANA BIOTECHNOLOGY INC$1,966,000
-91.2%
100,000
-85.0%
0.03%
-91.2%
WPFWS  FOLEY TRASIMENE ACQUISTN COR*w exp 05/26/202$1,611,000
+30.0%
774,3750.0%0.02%
+33.3%
EOCWU NewELLIOTT OPPORTUNITY II CORPunit 99/99/9999$1,502,000–150,000
+100.0%
0.02%–
ARYD  ARYA SCIENCES ACQU CORP IVcl a$1,072,000
+2.4%
100,0000.0%0.02%
+6.7%
EUCR  EUCRATES BIOMEDICAL ACQU COR$984,000
-1.4%
99,9990.0%0.02%0.0%
FHTX  FOGHORN THERAPEUTICS INC$896,000
-19.1%
84,0000.0%0.01%
-18.8%
FLAC  FRAZIER LIFESCIENCES ACQU CO$854,000
-2.0%
87,4980.0%0.01%0.0%
FSRXW NewFINSERV ACQUISITION CORP II*w exp 02/17/202$328,000–273,149
+100.0%
0.01%–
EUCRW  EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202$35,000
-16.7%
33,3330.0%0.00%0.0%
EBACW NewEUROPEAN BIOTECH ACQUTN CORP*w exp 03/06/202$95,000–100,000
+100.0%
0.00%–
TMPMW  TURMERIC ACQUISITION CORP*w exp 10/08/202$61,000
-9.0%
66,6660.0%0.00%0.0%
FLACW  FRAZIER LIFESCIENCES ACQU CO*w exp 11/30/202$32,000
+23.1%
29,1660.0%0.00%–
ARYA ExitARYA SCIENCES ACQUISITION CO$0–-14,835
-100.0%
-0.00%–
HLXA ExitHELIX ACQUISITION CORP$0–-35,344
-100.0%
-0.01%–
HSAQ ExitHEALTH SCIENCES ACQ CORP 2$0–-50,000
-100.0%
-0.01%–
DSEY ExitDIVERSEY HLDGS LTD$0–-107,301
-100.0%
-0.02%–
JWSWS ExitJAWS ACQUISITION CORP*w exp 99/99/999$0–-674,566
-100.0%
-0.03%–
EBACU ExitEUROPEAN BIOTECH ACQUTN CORPunit 03/09/2026$0–-300,000
-100.0%
-0.04%–
FSRXU ExitFINSERV ACQUISITION CORP IIunit 02/17/2026$0–-1,092,600
-100.0%
-0.16%–
MILE ExitMETROMILE INC$0–-1,400,010
-100.0%
-0.21%–
TTWO ExitTAKE-TWO INTERACTIVE SOFTWAR$0–-87,010
-100.0%
-0.23%–
LYFT ExitLYFT INC$0–-300,000
-100.0%
-0.28%–
FSRV ExitFINSERV ACQUISITION CORPcl a$0–-2,251,150
-100.0%
-0.44%–
IPOE ExitSOCIAL CAPITAL HEDOSOPHA HLDput$0–-1,750,000
-100.0%
-0.44%–
BMBL ExitBUMBLE INC$0–-643,500
-100.0%
-0.59%–
JWS ExitJAWS ACQUISITION CORP$0–-5,000,000
-100.0%
-0.98%–
FTCH ExitFARFETCH LTDord sh cl a$0–-1,335,000
-100.0%
-1.05%–
GH ExitGUARDANT HEALTH INC$0–-561,690
-100.0%
-1.27%–
SQ ExitSQUARE INCcl a$0–-400,950
-100.0%
-1.35%–
PINS ExitPINTEREST INCcl a$0–-1,411,165
-100.0%
-1.54%–
CTLT ExitCATALENT INC$0–-1,001,290
-100.0%
-1.56%–
SNAP ExitSNAP INCcl a$0–-2,401,668
-100.0%
-1.86%–
NKE ExitNIKE INCcl b$0–-1,076,000
-100.0%
-2.12%–
DIS ExitDISNEY WALT CO$0–-1,146,508
-100.0%
-3.13%–
DG ExitDOLLAR GEN CORP NEW$0–-1,046,810
-100.0%
-3.14%–
MCD ExitMCDONALDS CORP$0–-954,568
-100.0%
-3.16%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ADOBE SYSTEMS INCORPORATED33Q4 202113.2%
CONSTELLATION BRANDS INC20Q4 201810.9%
AMAZON COM INC20Q3 20238.0%
UNITEDHEALTH GROUP INC20Q3 20235.7%
IQVIA HLDGS INC19Q3 20237.3%
RESTAURANT BRANDS INTL INC18Q3 20198.9%
UNION PAC CORP17Q2 20235.1%
META PLATFORMS INC16Q3 202310.9%
COPART INC15Q4 20212.3%
SUTRO BIOPHARMA INC15Q3 20231.9%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SUVRETTA CAPITAL MANAGEMENT, LLC Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Zura Bio LtdJune 15, 20232,850,0006.6%
InflaRx N.V.April 24, 20235,733,91010.3%
Benitec Biopharma Inc.April 18, 20233,020,21410.0%
Aeglea BioTherapeutics, Inc.February 13, 20236,376,37310.0%
Bolt Biotherapeutics, Inc.Sold outFebruary 13, 202300.0%
Cano Health, Inc.Sold outFebruary 13, 202300.0%
CHIMERIX INCSold outFebruary 13, 202300.0%
Disc Medicine, Inc.Sold outFebruary 13, 202300.0%
OTONOMY, INC.Sold outFebruary 13, 202300.0%
Sio Gene Therapies Inc.Sold outFebruary 13, 202300.0%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export SUVRETTA CAPITAL MANAGEMENT, LLC's holdings

CSVXLS